(Q41198019)

28 September 2017

1 reference

title

Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist (English)

1 reference

28 September 2017

D J Triggle

1

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

American Journal of Cardiology

28 September 2017

published in

1 reference

28 September 2017

volume

78

1 reference

28 September 2017

issue

9A

1 reference

28 September 2017

page(s)

7-12

1 reference

Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Calcium channel antagonists. Part V: Second-generation agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Diltiazem and heart block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Selective inhibition of T-type Ca2+ channels by Ro 40-5967

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Classes of calcium channels in vertebrate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Molecular basis for Ca2+ channel diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Molecular biology of calcium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Molecular determinants of Ca2+ channel function and drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Calcium antagonists and vasodilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Characterization of ion channels seen in subconfluent human dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Lack of Negative Inotropic Effects of the New Calcium Antagonist Ro 40–5967 in Patients with Stable Angina Pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900732-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(96)00732-1

1 reference

28 September 2017

1 reference